November 8, 2018 Profiles in Business with Tucson Metro Chamber C-Path President and CEO Martha Brumfield, Ph.D., talks about today’s drug discovery process, C-Path’s global impact a
September 6, 2018 Doris Duke Charitable Foundation Awards Grant to Critical Path Institute to Advance Therapies for Sickle Cell Disease Contacts: Kissy Black, Critical Path Institute kissyblack@lotosnile.com, 615.298.1144 Kristin Roth-Schrefer, Communications Direct
August 10, 2018 CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer dis
August 10, 2018 Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho
July 26, 2018 First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti
May 18, 2018 “Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK”
May 7, 2018 C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou
April 26, 2018 CPTR Newsletter – April 2018 CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collabora
April 16, 2018 Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers Tucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path
February 12, 2018 Tucson-based Critical Path Institute emerging as top drug-research organization President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published Februa